Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.74B | 1.65B | 1.75B | 1.38B | 1.21B |
Gross Profit | 706.00M | 851.00M | 496.00M | 339.00M | 303.00M |
EBITDA | 254.00M | 345.00M | 300.00M | 145.00M | 209.00M |
Net Income | 143.00M | 188.00M | 190.00M | 236.00M | 253.00M |
Balance Sheet | |||||
Total Assets | 3.73B | 2.28B | 2.51B | 3.25B | 2.97B |
Cash, Cash Equivalents and Short-Term Investments | 334.00M | 437.00M | 475.00M | 110.00M | 371.00M |
Total Debt | 1.31B | 590.00M | 713.00M | 679.00M | 788.00M |
Total Liabilities | 2.14B | 1.04B | 1.32B | 1.63B | 1.51B |
Stockholders Equity | 1.59B | 1.24B | 1.19B | 1.62B | 1.45B |
Cash Flow | |||||
Free Cash Flow | 43.00M | 98.00M | 40.00M | -11.00M | 222.00M |
Operating Cash Flow | 164.00M | 208.00M | 118.00M | 137.00M | 374.00M |
Investing Cash Flow | -630.00M | -20.00M | 783.00M | -147.00M | -210.00M |
Financing Cash Flow | 367.00M | -215.00M | -598.00M | -247.00M | -29.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £1.19B | 22.62 | 12.12% | 0.73% | 0.49% | 14.18% | |
79 Outperform | £2.81B | 20.95 | 14.14% | 193.49% | 4.77% | 18.94% | |
75 Outperform | £16.07B | 12.70 | 11.89% | 279.75% | -0.38% | 14.68% | |
74 Outperform | £775.51M | 19.72 | 12.74% | 399.31% | -0.03% | 7.88% | |
70 Outperform | £1.65B | 13.38 | 9.02% | 146.14% | 1.01% | 11.12% | |
66 Neutral | £2.34B | 37.44 | 3.39% | 373.23% | 5.40% | -67.46% | |
53 Neutral | C$4.38B | 4.26 | -20.57% | 3.54% | 8.18% | 1.50% |
Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, has acquired 15,000 ordinary shares at a price of £5.185 each, increasing her total holding to 70,000 shares. This transaction, conducted on the London Stock Exchange, aligns with the Market Abuse Regulation requirements and reflects confidence in the company’s future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC hosted a Capital Markets event in London to discuss its strategy and growth opportunities, emphasizing its role in the future of food. The event highlighted the company’s expanded portfolio and capabilities, including the integration with CP Kelco, which enhances its solutions offering. The company aims to accelerate top-line growth by addressing societal trends and investing in new technologies. The event did not provide new financial updates but showcased the company’s focus on healthier, more sustainable food solutions.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC, a UK-based company, has announced a change in the voting rights held by BlackRock, Inc., an American multinational investment management corporation. BlackRock’s voting rights in Tate & Lyle have fallen below 5%, indicating a reduction in their stake in the company. This adjustment in BlackRock’s holdings may impact Tate & Lyle’s shareholder dynamics and influence within the market.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced the grant of awards over ordinary shares as part of its Performance Share Plan 2020 to key managerial personnel, including CEO Nick Hampton and CFO Sarah Kuijlaars. These conditional awards are contingent on meeting specific performance criteria over a three-year period, reflecting the company’s commitment to aligning management incentives with long-term performance goals.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced the availability of its Annual Financial Report and the Notice of its Annual General Meeting (AGM) for 2025. The AGM is scheduled to take place on July 24, 2025, at the Royal College of Nursing in London. These documents have been submitted to the National Storage Mechanism and are accessible on the company’s website. This announcement ensures transparency and keeps shareholders informed of the company’s financial status and upcoming governance activities, reinforcing Tate & Lyle’s commitment to stakeholder engagement and regulatory compliance.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving its Chief Executive, Nick Hampton, who acquired shares under the company’s Group Bonus Plan and Performance Share Plan. The transaction reflects the fulfillment of employment and performance conditions tied to these plans, impacting the executive’s shareholding in the company. This development underscores the company’s adherence to regulatory requirements and its commitment to aligning executive compensation with performance metrics.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £1000.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced its issued share capital as of May 30, 2025, totaling 476,739,452 ordinary shares, with 31,294,579 held in treasury and not carrying voting rights. This results in 445,444,873 voting rights, a figure that shareholders can use to assess their interest in the company under regulatory rules, potentially impacting shareholder notifications and transparency obligations.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, acquired 15,000 ordinary shares at £5.62498 each, totaling £84,374.70, on May 28, 2025. This transaction, conducted on the London Stock Exchange, increases her total shareholding to 55,000 shares, reflecting confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving the purchase of American Depositary Receipts (ADRs) by the Kimberly A Nelson Revocable Trust, a person closely associated with Kimberly A. Nelson, a director of the company. The transaction, which took place on May 23, 2025, involved the acquisition of 250 ADRs at a price of $30.40 each, representing an interest in 1,642 ADRs or 6,568 ordinary shares. This notification complies with the Market Abuse Regulation and reflects the company’s commitment to transparency in its managerial transactions.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that its CEO, Nick Hampton, has exercised options to acquire 3,321 ordinary shares under the Tate & Lyle 2020 Sharesave Scheme at a price of 542 pence per share. This transaction, conducted outside a trading venue, reflects the company’s adherence to the Market Abuse Regulation and highlights the CEO’s continued investment in the company, potentially signaling confidence in its future performance.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £8.20 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced a change in major holdings, with BlackRock, Inc. adjusting its voting rights in the company. As of May 12, 2025, BlackRock’s total voting rights in Tate & Lyle have decreased from 5.45% to 5.25%. This change in holdings could impact the company’s shareholder dynamics and influence future strategic decisions, reflecting BlackRock’s ongoing adjustments in its investment strategy.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £880.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a change in the voting rights held by BlackRock, Inc., which now holds 5.45% of the total voting rights in the company. This adjustment in BlackRock’s holdings may impact Tate & Lyle’s shareholder dynamics and influence future corporate decisions, reflecting BlackRock’s strategic interest in the company.
BlackRock, Inc., a major shareholder in Tate & Lyle PLC, has adjusted its voting rights holdings, now holding 5.45% of the total voting rights. This change in BlackRock’s stake reflects a slight decrease in direct voting rights but maintains the overall percentage, potentially impacting shareholder dynamics and influencing future corporate decisions.
Tate & Lyle has announced a change in the voting rights held by BlackRock, Inc., a major shareholder. As of April 25, 2025, BlackRock’s total voting rights in Tate & Lyle have increased from 5.26% to 5.45%, indicating a slight increase in their stake. This adjustment in holdings reflects BlackRock’s continued interest and investment in Tate & Lyle, potentially impacting the company’s governance and strategic decisions.
Tate & Lyle PLC has announced a change in the voting rights held by Black Creek Investment Management Inc., a Canadian investment management company. The notification indicates that Black Creek’s voting rights have decreased slightly from 3.024979% to 2.992493%, involving shares beneficially owned by 12 separate funds and clients. This adjustment in holdings does not affect any single fund or client reaching the 3% threshold, and Black Creek retains the discretion to exercise voting rights for the shares held.